Onward Medical N.V. (EBR:ONWD)

Belgium flag Belgium · Delayed Price · Currency is EUR
3.460
-0.045 (-1.28%)
At close: Mar 20, 2026
Market Cap193.79M -10.3%
Revenue (ttm)2.72M +226.9%
Net Income-38.65M
EPS-0.78
Shares Out56.01M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume203,680
Average Volume118,403
Open3.550
Previous Close3.505
Day's Range3.455 - 3.590
52-Week Range3.455 - 5.770
Beta0.89
RSI27.15
Earnings DateMar 31, 2026

About Onward Medical

Onward Medical N.V., a medical technology company, develops and commercializes therapies to enable functional recovery for people with Spinal Cord Injury (SCI). The company engages in developing ARCEX, a technology to enhance hand strength and sensation for individuals with SCI; ARCIM, a spinal cord stimulation system designed to address blood pressure instability and other symptoms in people with SCI; ARCBCI, an implanted brain-computer interface to restore thought-driven movement. It operates in France, Germany, the Netherlands, the United Ki... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2014
Employees 103
Stock Exchange Euronext Brussels
Ticker Symbol ONWD
Full Company Profile

Financial Performance

In 2024, Onward Medical's revenue was 1.74 million, an increase of 226.88% compared to the previous year's 532,000. Losses were -35.73 million, -1.26% less than in 2023.

Financial Statements